TechCrunch·3 min read

Mantis Biotech is making ‘digital twins’ of humans to help solve medicine’s data availability problem

Mantis Biotech develops digital twins for biomedical research.

Mantis Biotech, based in New York, is pioneering the development of digital twins—predictive models of human anatomy and behavior—by integrating diverse data sources. This innovative platform aims to fill critical gaps in biomedical research, particularly for rare diseases, by generating synthetic datasets that can enhance clinical decision-making and improve patient outcomes. The company has already found traction in professional sports, with an NBA team utilizing its technology to analyze athlete performance over time.

Key Takeaways

  • 1.

    Mantis Biotech raised $7.4 million in seed funding to enhance its platform.

  • 2.

    The startup's technology is currently being utilized by an NBA team for athlete performance modeling.

  • 3.

    Mantis aims to target preventative healthcare and pharmaceutical labs in future expansions.

Get your personalized feed

Trace groups the biggest stories, videos, and discussions into one feed so you can stay current without scanning ten tabs.

Try Trace free
Mantis Biotech is making ‘digital twins’ of humans to help solve medicine’s data availability problem | Trace